Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Actavis Inc    

ACTAVIS INC
Mes dernières consult.
Most popular
Report
No quotes available
-- USD   --.--%
12/08 TEVA CONSIDERIN : Bloomberg
12/08 TEVA CONSIDERIN : Bloomberg
12/07 EDITAS MEDICINE : BioCentury - Editas raises $50M follow-on
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on ACTAVIS INC
10/11 ALLERGAN : to Present Data From More Than 20 Abstracts at the 2017 Fall Clinical..
10/11 ALLERGAN : to Present New Dry Eye Data at the American Academy of Optometry Meet..
10/10 ALLERGAN : Announces that the FDA Accepts New Drug Application for Ulipristal Ac..
10/10 ALLERGAN : Generic Drugs Stock Performance Review -- Catalyst Pharma, Flexion Th..
10/09 JUDGE QUESTIONS ALLERGAN PLC (NYSE : AGN) Patent Agreement With Mohawk Tribe
10/09 ALLERGAN : to Present New Dry Eye Data at the American Academy of Optometry Meet..
10/07 ALLERGAN : AMCP Foundation and Allergan Offered Summer Internships in Managed Ca..
10/06 ALLERGAN : To Present New Data From Its Anti-Infectives Portfolio At IDWeek 2017..
10/05 ALLERGAN : Presents Data From Seventeen Abstracts At The 2017 American Society F..
10/05 ALLERGAN : Receives Refusal to File Letter from FDA for Vraylar® cariprazine Sup..
10/05 ALLERGAN : Trump to keep Obama rule curbing corporate tax inversion deals
10/05 ALLERGAN : Trump to keep Obama rule curbing corporate tax inversion deals
10/05 ALLERGAN PLC ORDINARY SHARES (NYSE : AGN)’s Botox Gets FDA Approval For Th..
10/05 ALLERGAN : FDA Approves BOTOX Cosmetic for the Temporary Improvement in the Appe..
10/04 ALLERGAN : Allergans Botox gets US FDA green light to treat forehead lines
10/04 ALLERGAN : To Present New Data From Its Anti-Infectives Portfolio At IDWeek 2017..
10/04 ALLERGAN : to Report Third Quarter 2017 Earnings and Host Conference Call and We..
10/04 ALLERGAN : FDA Accepts Supplemental New Drug Application filing for AVYCAZ
10/03 ALLERGAN : U.S. House committee launches probe of Allergan patent deal
10/03 ALLERGAN : U.S. House committee launches probe of Allergan patent deal
10/03 SHIRE PLC (ADR)(NASDAQ : SHPG) Sues Allergan Over Anti-Competitive Behavior
10/03 ALLERGAN : FDA Approves BOTOX® Cosmetic (OnabotulinumtoxinA) for the Temporary I..
10/03DJSHIRE : Files Antitrust Lawsuit Against Rival -- WSJ
10/02DJSHIRE : Alleges Allergan Blocked Drug From Medicare Contracts -- Update
10/02 ALLERGAN : Shire sues Allergan in U.S. over dry eye drug
10/02DJSHIRE : Alleges Allergan Blocked Drug From Medicare Contracts
10/02 ALLERGAN : FDA Accepts Supplemental New Drug Application (sNDA) filing for AVYCA..
10/02 ALLERGAN : to Report Third Quarter 2017 Earnings and Host Conference Call and We..
09/28 ALLERGAN : New Data from CENTAUR Phase 2b Clinical Study Supports Continued Deve..
09/28 ALLERGAN : ACZONE Gel, 7.5% Recognized With Teen Vogue Acne Award Win
09/28 SENATORS WANT PROBE OF ALLERGAN TRAN : letter
09/28 SENATORS WANT PROBE OF ALLERGAN TRAN : letter
09/27 ALLERGAN : Sen. Hassan Leads Colleagues in Calling for Investigation Into Allerg..
09/27 ALLERGAN : New Study Showcases Economic Impact of Allergan Operations on French ..
09/27 ALLERGAN : Announces Tessa Hilado Executive Vice President and Chief Financial O..
09/27 ALLERGAN : Board of Directors Authorizes New $2 Billion Share Repurchase Program..
09/27 ALLERGAN : Sen. Margaret Wood Hassan (D-NH) News Release
09/26 ALLERGAN : shares puff up in pre-market as it announces latest share buy-back an..
09/26 ALLERGAN : New Data from CENTAUR Phase 2b Clinical Study Supports Continued Deve..
09/26 ALLERGAN : Receives Refusal to File Letter from FDA for Vraylar Supplemental New..
09/26 ALLERGAN : ACZONE® (dapsone) Gel, 7.5% Recognized With Teen Vogue Acne Award Win
09/26 ALLERGAN PLC : Featured Company News - Allergan Gets a Refusal to File Letter fr..
09/25 ALLERGAN PLC (NYSE : AGN) Files An 8-K Departure of Directors or Certain Officer..
09/25 ALLERGAN PLC : Change in Directors or Principal Officers (form 8-K)
09/25 ALLERGAN : boosts shares with $2 billion buyback
09/25 ALLERGAN : New Study Showcases Economic Impact of Allergan Operations on French ..
09/25 ALLERGAN : Announces Tessa Hilado, Executive Vice President and Chief Financial ..
09/25 ALLERGAN : Board of Directors Authorizes New $2 Billion Share Repurchase Program..
09/25 Opdivo, Keytruda Back In The News, FDA Snubs AGN, EARS Catches Eyes
09/22 ALLERGAN : Receives Refusal to File Letter from FDA for Vraylar® (cariprazine) S..
09/22 ALLERGAN : Native American tribe moves to dismiss Allergan patent case
09/22 ALLERGAN : New Data from CENTAUR Phase 2b Clinical Study Supports Continued Deve..
09/21 ALLERGAN : Allergan Innovation Recognized With Three 2017 Allure Best of Beauty ..
09/20DJMakers Of Opioids Are Asked For Data -- WSJ
09/19DJStates Push Ahead With Investigation Into Opioid Painkillers
09/19 ALLERGAN : Innovation Recognized With Three 2017 Allure Best of Beauty Breakthro..
09/19 Attorney General Cynthia Coffman joins expanded probe into opioid manufacture..
09/16 AMGEN : A Biosimilar Cure for Sky-High Cancer Drug Prices
09/15 IMPRIMIS PHARMACEUTICALS : Releases Statement Regarding Allergan Lawsuit
09/15 Indivior files lawsuits against Suboxone generic rivals
09/14 ALLERGAN : FDA Approves Amgen And Allergan's MVASI(TM) (bevacizumab-awwb) For Th..
09/14 ALLERGAN : to Present New Data on Chronic Migraine at the International Headache..
09/14 ALLERGAN : Lyndra, Inc. and Allergan Sign a Partnership to Develop Ultra-Long-Ac..
09/14 ALLERGAN : Pro Football Hall of Famer Deion Sanders Tackles Frown Lines And Crow..
09/14 ALLERGAN : Mylan calls Allergans patent deal with Indian tribe a sham transactio..
09/14 ALLERGAN : accused of taking advantage of tribal sovereignty in patent dispute w..
09/14 ALLERGAN : Launches New Brilliant Distinctions Patient Loyalty Program
09/13 ALLERGAN : Foundation to Donate $150,000 to Support Hurricane Irma Relief Effort..
09/12 ALLERGAN : Launches New Brilliant Distinctions® Patient Loyalty Program
09/12 ALLERGAN : and Saint Regis Mohawk Tribe Announce Agreements Regarding RESTASIS P..
09/12 AMGEN : and Allergan Present Phase 3 Data on Biosimilar Trastuzumab Candidate AB..
09/12 ALLERGAN : s Patent Loophole Could Be a Huge Gift for Pfizer
09/12DJOpioid Makers Challenge Suit -- WSJ
09/11DJOpioid Painkiller Makers Seek to Dismiss State Lawsuit
09/11 ALLERGAN : Lyndra, Inc. and Allergan Sign a Partnership to Develop Ultra-Long Ac..
Prev.1   2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2017 15 894 M
EBIT 2017 7 658 M
Net income 2017 -5 870 M
Debt 2017 24 765 M
Yield 2017 1,71%
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 5,07x
EV / Sales 2018 5,02x
Capitalization 55 807 M
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 225 $
Spread / Average Target 34%
EPS Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Robert A. Stewart Chief Operating Officer
Maria Teresa Hilado Chief Financial Officer
C. David Nicholson Chief Research & Development Officer
Paul M. Bisaro Director
Sector and Competitors
1st jan.Capitalization (M$)
ACTAVIS INC55 807
JOHNSON & JOHNSON21.23%377 698
NOVARTIS11.34%218 728
PFIZER9.48%213 036
ROCHE HOLDING LTD.6.19%208 877
MERCK AND COMPANY-7.68%151 559